<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pan Z</submitter><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371041</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Antipsychotic drugs have been shown to suppress tumor growth and induce cell death, but their clinical application remains limited. Pimozide, an FDA-approved antipsychotic, holds significant potential for cancer treatment. However, the mechanisms underlying tumor cell responses to Pimozide remain unclear. In this study, we identify a critical role for peroxisomes in mediating tumor cell resistance to Pimozide. Our findings demonstrate that Pimozide increases peroxisome numbers and that peroxisomal deficiency significantly enhances Pimozide-induced cell death. We show that peroxisomes mitigate Pimozide-induced apoptosis primarily through fatty acid oxidation and ether lipid synthesis, rather than reactive oxygen species (ROS) metabolism. Moreover, Pimozide treatment upregulates peroxisomal </pubmed_abstract><journal>Oncogenesis</journal><pubmed_title>Peroxisomal lipid metabolism inhibits Pimozide-induced cancer cell death by regulating ATP homeostasis.</pubmed_title><pmcid>PMC12371041</pmcid><funding_grant_id>32170736</funding_grant_id><funding_grant_id>32370776</funding_grant_id><pubmed_authors>Pan Z</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Yu F</pubmed_authors><pubmed_authors>Cui F</pubmed_authors><pubmed_authors>You W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peroxisomal lipid metabolism inhibits Pimozide-induced cancer cell death by regulating ATP homeostasis.</name><description>Antipsychotic drugs have been shown to suppress tumor growth and induce cell death, but their clinical application remains limited. Pimozide, an FDA-approved antipsychotic, holds significant potential for cancer treatment. However, the mechanisms underlying tumor cell responses to Pimozide remain unclear. In this study, we identify a critical role for peroxisomes in mediating tumor cell resistance to Pimozide. Our findings demonstrate that Pimozide increases peroxisome numbers and that peroxisomal deficiency significantly enhances Pimozide-induced cell death. We show that peroxisomes mitigate Pimozide-induced apoptosis primarily through fatty acid oxidation and ether lipid synthesis, rather than reactive oxygen species (ROS) metabolism. Moreover, Pimozide treatment upregulates peroxisomal </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-09T10:47:29.708Z</modification><creation>2026-04-08T00:48:10.883Z</creation></dates><accession>S-EPMC12371041</accession><cross_references><pubmed>40841534</pubmed><doi>10.1038/s41389-025-00575-0</doi></cross_references></HashMap>